Robert Neumann
University of Colorado Boulder
13 Papers
68 Citations
Robert Neumann is an academic researcher from University of Colorado Boulder. The author has contributed to research in topics: Medicine & Cefepime. The author has an hindex of 7, co-authored 13 publications. Previous affiliations of Robert Neumann include University of Colorado Denver.
Chat about Author
Papers
Stroke Alert Program Improves Recognition and Evaluation Time of In-Hospital Ischemic Stroke
TL;DR: An inpatient stroke alert program is effective in decreasing evaluation time for in-hospital strokes, although response times remain significantly longer than those in the emergency department.
32
Recognizing false ischemic penumbras in CT brain perfusion studies.
Alan C. Best,Natasha R Acosta,Jennifer E Fraser,Manuel Thomas Borges,Kerry E. Brega,Tracey Anderson,Robert Neumann,Alexander Ree,Robert J. Bert +8 more
TL;DR: The authors identify five possible causes of false penumbras, each of which produces a different pattern at imaging: upstream flow restriction, evolution of ischemic change, vascular dysregulation, positioning of the patient's head at an angle during image acquisition, and variant anatomy in the circle of Willis.
31
Ruptured Distal Posterior Inferior Cerebellar Artery (PICA) Aneurysms Associated with Cerebellar Arterial Venous Malformations (AVMs): A Case Series and Review of the Literature Demonstrating the Need for Angiographic Evaluation and Feasibility of Endovascular Treatment.
David Case,David A. Kumpe,Luis Cava,Robert Neumann,Andrew M. White,Christopher Roark,Joshua Seinfeld +6 more
TL;DR: A case series shows a specific anatomical pattern for these aneurysms, an underreported need for conventional digital subtraction angiography (DSA) during evaluation, along with the utility of endovascular treatment with liquid embolic agents, and a feasible and useful management strategy.
21
A Randomized Pharmacokinetic and Pharmacodynamic Evaluation of Every 8‐Hour and 12‐Hour Dosing Strategies of Vancomycin and Cefepime in Neurocritically ill Patients
Lynn Kassel,Edward T. Van Matre,Charles J. Foster,Douglas N. Fish,Scott W. Mueller,Deb S. Sherman,Michael F. Wempe,Robert MacLaren,Robert Neumann,Tyree H. Kiser +9 more
TL;DR: Neurocritically ill patients have clinically significant alterations in pharmacokinetic parameters of renally eliminated medications that may result in subtherapeutic plasma and cerebrospinal fluid antibiotic concentrations.
15
Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration.
Edward T. Van Matre,Scott W. Mueller,Douglas N. Fish,Robert MacLaren,Luis Cava,Robert Neumann,Tyree H. Kiser +6 more
TL;DR: CVVH is highly effective in removing levetiracetam from circulating plasma and standard doses of levetIRacetam are required to maintain adequate plasma concentrations, due to the effective removal.